Skip to main content
. 2021 Sep 14;196(1):146–155. doi: 10.1111/bjh.17815

Fig 1.

Fig 1

Risk of transformation from diagnosis in the 84 patients with SMZL from the HCB . (A) Cumulative incidence of histological transformation, (B) Cumulative incidence according to ILL risk score, and (C) Cumulative incidence according to HPLL/ABC risk score. HBC, Hospital Clinic of Barcelona; HPLL, Haemoglobin, Platelet count, lactate dehydrogenase and extrahilar Lymphadenopathy; ILL, Intergruppo Italiano Linfomi; SMZL, splenic marginal zone lymphoma.